Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Regulatory Freelancing: Rare Disease Group Hopes To Shape FDA Guidance

Apr 22 2013

• By Derrick Gingery

Related Content

FDA To Provide Expedited Approval Desktop Reference

Oct 29 2012

“Breakthrough Therapy”: New Pathway in FDASIA May Point The Way To Future Reforms

Aug 16 2012

Should FDA Be Forced To Consider Development Time And Cost?

Nov 12 2012

FDASIA Is Signed, Not That White House Wanted Anyone To Notice

Jul 16 2012

Regulatory Flexibility Staring Contest: Will Industry Or FDA Blink First?

Oct 24 2011

PDUFA V: Accelerated Approval Expansion May Outshine Rare Disease Improvements

Sep 17 2012

Related Companies

Takeda Pharmaceutical Co. Ltd.

Additional Topics

United States Drug Approval Standards Regulation BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window